Could a probiotic soothe fibromyalgia pain in young people?

NCT ID NCT07738926

First seen Jul 31, 2026 ยท Last updated Jul 31, 2026

Summary

This study tests whether a daily probiotic supplement, Bifidobacterium adolescentis PRL2019, can reduce pain in young people aged 9 to 25 with juvenile fibromyalgia, a condition marked by widespread musculoskeletal pain. Participants will take the probiotic or a placebo for 12 weeks, then switch, allowing each person to serve as their own comparison. The trial measures changes in pain scores and other symptoms to see if gut bacteria modulation might offer relief.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Bifidobacterium adolescentis PRL2019 (probiotic supplement)
What this could lead to
If effective, this probiotic could offer a simple, well-tolerated option to reduce pain and improve quality of life for young people with fibromyalgia.
What could go wrong
This is a small early-stage trial, and the supplement may not outperform placebo. Effects on pain could be modest, and individual responses may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • IRCCS Giannina Gaslini

    Genova, Genova, 16147, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.